Search results:


The pahtway p364 has 29 genes in the original annotation. Currently, there are 21 genes in SZGR (with evidence in schizophrenia) that are present at this pathway.

Gene ID Symbol Synonyms Official Full Name Start Site End Site Location
920CD4CD4mutCD4 molecule12p13.31
3458IFNGIFG | IFIinterferon, gamma12q14
7043TGFB3ARVD | ARVD1 | LDS5 | RNHF | TGF-beta3transforming growth factor beta 314q24
6351CCL4ACT2 | AT744.1 | G-26 | HC21 | LAG-1 | LAG1 | MIP-1-beta | MIP1B | MIP1B1 | SCYA2 | SCYA4C-C motif chemokine ligand 417q12
6348CCL3G0S19-1 | LD78ALPHA | MIP-1-alpha | MIP1A | SCYA3C-C motif chemokine ligand 317q12
7040TGFB1CED | DPD1 | LAP | TGFB | TGFbetatransforming growth factor beta 119q13.1
3460IFNGR2AF-1 | IFGR2 | IFNGT1 | IMD28interferon gamma receptor 2 (interferon gamma transducer 1)21q22.11
8809IL18R1CD218a | CDw218a | IL-1Rrp | IL18RA | IL1RRPinterleukin 18 receptor 12q12
7852CXCR4CD184 | D2S201E | FB22 | HM89 | HSY3RR | LAP-3 | LAP3 | LCR1 | LESTR | NPY3R | NPYR | NPYRL | NPYY3R | WHIM | WHIMSC-X-C motif chemokine receptor 42q21
940CD28Tp44CD28 molecule2q33
1230CCR1CD191 | CKR-1 | CKR1 | CMKBR1 | HM145 | MIP1aR | SCYAR1C-C motif chemokine receptor 13p21
1232CCR3CC-CKR-3 | CD193 | CKR3 | CMKBR3C-C motif chemokine receptor 33p21.3
729230CCR2CC-CKR-2 | CCR-2 | CCR2A | CCR2B | CD192 | CKR2 | CKR2A | CKR2B | CMKBR2 | MCP-1-RC-C motif chemokine receptor 23p21.31
1234CCR5CC-CKR-5 | CCCKR5 | CCR-5 | CD195 | CKR-5 | CKR5 | CMKBR5 | IDDM22C-C motif chemokine receptor 5 (gene/pseudogene)3p21.31
3592IL12ACLMF | IL-12A | NFSK | NKSF1 | P35interleukin 12A3q25.33
3558IL2IL-2 | TCGF | lymphokineinterleukin 24q26-q27
3565IL4BCGF-1 | BCGF1 | BSF-1 | BSF1 | IL-4interleukin 45q31.1
3567IL5EDF | IL-5 | TRFinterleukin 55q31.1
1437CSF2GMCSFcolony stimulating factor 25q31.1
3593IL12BCLMF | CLMF2 | IL-12B | IMD28 | IMD29 | NKSF | NKSF2interleukin 12B5q33.3
959CD40LGCD154 | CD40L | HIGM1 | IGM | IMD3 | T-BAM | TNFSF5 | TRAP | gp39 | hCD40LCD40 ligandXq26


Copyright © Bioinformatics and Systems Medicine Laboratory All Rights Reserved since 2009.